Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adverum Biotechnologies

2.32
-0.0700-2.93%
Post-market: 2.320.00000.00%18:51 EDT
Volume:79.67K
Turnover:184.82K
Market Cap:48.47M
PE:-0.32
High:2.43
Open:2.35
Low:2.27
Close:2.39
Loading ...

RBC Capital Keeps Their Hold Rating on Adverum Biotechnologies (ADVM)

TIPRANKS
·
16 Apr

TD Cowen Reaffirms Their Buy Rating on Adverum Biotechnologies (ADVM)

TIPRANKS
·
16 Apr

Adverum Biotechnologies Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
15 Apr

Adverum Biotechnologies: Q4 Earnings Snapshot

Associated Press Finance
·
15 Apr

Adverum Biotechnologies Q4 EPS $(1.96) Misses $(1.38) Estimate

Benzinga
·
15 Apr

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones

GlobeNewswire
·
15 Apr

North American Morning Briefing: China Raises Tariffs on U.S. in Latest Salvo

Dow Jones
·
11 Apr

ADVISORY-Alert on Adverum Biotechnologies from press release by law firm withdrawn

Reuters
·
08 Apr

U.S. RESEARCH ROUNDUP- BlackRock, Morgan Stanley, ServiceNow

Reuters
·
08 Apr

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
05 Apr

North American Morning Briefing: Stock Futures Fall, Bonds Rally as Investors Negotiate Market Turmoil

Dow Jones
·
04 Apr

Major Shareholder Makes Bold Move in Adverum Biotechnologies!

TIPRANKS
·
03 Apr

Adverum Biotechnologies Inc expected to post a loss of $1.36 a share - Earnings Preview

Reuters
·
02 Apr

BRIEF-Adverum Biotechnologies Inc - Some Prior Financial Statements Should No Longer Be Relied Upon - SEC Filing

Reuters
·
01 Apr

Adverum Biotechnologies Faces Subtenant Default Situation

TIPRANKS
·
01 Apr

Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference

GlobeNewswire
·
01 Apr

Major Moves by Shareholder: Adverum Biotechnologies Stock in Focus

TIPRANKS
·
28 Mar

Adverum Biotechnologies Inc expected to post a loss of $1.36 a share - Earnings Preview

Reuters
·
26 Mar

North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs

Dow Jones
·
21 Mar

Adverum Biotechnologies Inc expected to post a loss of $1.36 a share - Earnings Preview

Reuters
·
14 Mar